Kestra Medical Technologies, Ltd. KMTS NASDAQ

Kestra Medical Technologies, Ltd. (KMTS) reported total assets of $379.34M and total liabilities of $91.35M for quarter ending 2026-01-31, resulting in total equity of $287.99M.

The company held $291.32M in cash and short-term investments. Total debt stood at $4.29M, with net debt of $-287.04M. The Debt-to-Equity (D/E) ratio was 0.01 (conservative).

Current ratio is 7.32, indicating strong short-term liquidity. Interest coverage is -18.4x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (55/100) — Total assets $379.34M and equity $287.99M support the company's competitive scale
• VALUE (71/100) — Debt-to-Equity 0.01 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 49/100 with 2/7 criteria passed.